hCD28/hCD3EDG/hCD19
品系全名
C57BL/6Smoc-Cd28em2(hCD28)Cd3etm1(hCD3E)Cd3dtm1(hCD3D)Cd3gtm1(hCD3G)Cd19em1(hCD19)Smoc
目錄號
NM-XA-240981
品系狀態(tài)
活體
品系描述
驗證數(shù)據(jù)
Fig.1 CD3 specific expression analysis in WT C57BL/6 and HO/HO/HO hCD3EDG/hCD28/hCD19 mice in peripheral blood, lymph node and spleen.
Fig.2 CD19 specific expression analysis in WT C57BL/6 and HO/HO/HO hCD3EDG/hCD28/hCD19 mice in peripheral blood, lymph node and spleen.
Fig.3 CD28 specific expression analysis in WT C57BL/6 and HO/HO/HO hCD3EDG/hCD28/hCD19 mice in peripheral blood, lymph node and spleen.
Fig.4 Frequency of leukocyte subpopulations in WT C57BL/6 and HO/HO/HO hCD3EDG/hCD28/hCD19 mice by flow cytometry.
Fig.5 Frequency of leukocyte subpopulations in WT C57BL/6 and HO/HO/HO hCD3EDG/hCD28/hCD19 mice in (A)? lymph node, (B) peripheral blood(PB) and (C) spleen by flow cytometry(female, 5-6-week-old, n=3).
Fig.6 Organ index of WT C57BL/6 and HO/HO/HO hCD3EDG/hCD28/hCD19 mice (female, 5-6-week-old, n=3).
你也可能感興趣
Cre-ERT2在無Tamoxifen誘導(dǎo)的情況下,在細(xì)胞質(zhì)內(nèi)處于無活性狀態(tài);當(dāng)Tamoxifen誘導(dǎo)后,Tamoxifen的代謝產(chǎn)物4-OHT(雌激素類似物)與ERT結(jié)合,可使Cre-ERT2進(jìn)核發(fā)揮Cre重組酶活性。
查看常見的基因工程小鼠可以分為兩種命名方式,包括基因定點修飾的小鼠命名,比如:敲除、敲入、點突變等等,和隨機轉(zhuǎn)基因的小鼠命名。
查看